Stocks and Investing Stocks and Investing
Fri, December 22, 2023
Thu, December 21, 2023
Wed, December 20, 2023
Tue, December 19, 2023

Jeffrey Hung Upgraded (ACAD) to Buy and Increased Target to $40 on, Dec 19th, 2023


Published on 2024-10-28 08:04:29 - WOPRAI, Jeffrey Hung
  Print publication without navigation


Jeffrey Hung of Morgan Stanley, Upgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Buy and Increased Target from $31 to $40 on, Dec 19th, 2023.

Jeffrey has made no other calls on ACAD in the last 4 months.



There are 11 other peers that have a rating on ACAD. Out of the 11 peers that are also analyzing ACAD, 2 agree with Jeffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $27 on, Monday, December 18th, 2023
  • Neena Bitritto-Garg of "Deutsche Bank" Downgraded from Strong Buy to Hold and Held Target at $25 on, Thursday, December 14th, 2023


These are the ratings of the 9 analyists that currently disagree with Jeffrey


  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $42 on, Thursday, December 14th, 2023
  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $38 on, Wednesday, December 13th, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $40 on, Monday, November 6th, 2023
  • Uy Ear of "Mizuho" Upgraded from Hold to Strong Buy and Increased Target to $35 on, Monday, November 6th, 2023
  • Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $33 on, Friday, November 3rd, 2023
  • Jason Butler of "JMP Securities" Maintained at Buy with Increased Target to $42 on, Friday, November 3rd, 2023
  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $33 on, Tuesday, October 17th, 2023
  • Tessa Romero of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $32 on, Tuesday, October 10th, 2023
  • Sarah James of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $42 on, Tuesday, August 22nd, 2023